Turnover: 183.6 million EUR (2020)

Country: France

Since its foundation in 1980, Arkopharma has specialized in plant-based medicines. After phytotherapy was recognized by the French Ministry of Health in 1986, Arkopharma went international, distinguishing itself with its 100% plant-based product range. Today, the company is the French and European leader in plant-based medicines and dietary supplements.

In 2010, sales were €175 million, rising to €205 million in 2016. 92% of sales are generated in Europe, particularly France (56%). The largest share of sales is generated by phytotherapy products, which accounted for 91.2 million euros in 2016.[Arkopharma Annual Report 2016]

In the pharmacy dietary supplements market, with 69 million units sold in 2016, Arkopharma holds a 13.5% market share, making it the market leader. Arkopharma is positioned as the undisputed European leader in phytotherapy, with over 40% pharmacy market share.[Arkopharma Annual Report 2016]

The top-selling dietary supplements in 2016 were for: vitality (11.6M units sold), stress (11.4M units sold) and digestion (10.4 units sold).

in 2016, Arkopharma had 52 registrations and marketing authorizations for phytotherapies, issued by the ANSM.

Studies mentioning this company

The herbal medicine market - France

Other companies mentioned:

The food supplements market - France

Other companies mentioned:

The pharmacy market - France

Other companies mentioned: